Dr Reddys Laboratories Share Price Today - Live Blog for June 04, 2025

There was no change in the share price of Dr Reddys Laboratories Ltd, and it continues to trade at ₹1,252.00. The stock has a PE ratio of 18.4200, an ROE of 16.8559%, and a debt to equity ratio of 0.1394.

With a -0.10% decrease, Dr Reddys Laboratories Ltd's share price is now at ₹1,251.45. The stock is currently trading at a PE of 18.4200, while the industry PE is 33.7937, prompting investors to assess its value proposition.

The share price of Dr Reddys Laboratories Ltd soared by an impressive 0.18%, marking a substantial gain for investors. At present, this stock can be acquired at a current market price of ₹1,253.30 per share.

Dr Reddys Laboratories Ltd experienced a -0.15% dip in its share price and is currently trading at ₹1,251.25. The stock has a PE ratio of 18.4200, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

With a -0.23% decrease, Dr Reddys Laboratories Ltd's share price is now at ₹1,254.00. The stock is currently trading at a PE of 18.4200, while the industry PE is 33.7937, prompting investors to assess its value proposition.

In recent times, Dr Reddys Laboratories Ltd witnessed a decline of -0.23% in its share price, and it currently trades at ₹1,254.00 per share. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

The stock of Dr Reddys Laboratories Ltd is facing a -0.03% decline and is currently trading at ₹1,256.15 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

Dr Reddys Laboratories Ltd's share price has fallen by -0.01%, a situation worth noting. At present, the stock is trading at ₹1,256.15. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 18.4200, while the industry PE ratio is 33.7937.

The stock of Dr Reddys Laboratories Ltd suffered a -0.01% decline, and it currently trades at ₹1,256.00 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

Dr Reddys Laboratories Ltd's stock price surged by 0.03%, reaching the current market value of ₹1,256.15 per share. This surge is a testament to the stock's recent performance.

The stock of Dr Reddys Laboratories Ltd is facing a -0.18% decline and is currently trading at ₹1,256.20 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

The share price of Dr Reddys Laboratories Ltd experienced an uptrend, surging by 0.11% recently. As of now, this stock is actively trading at a current market price of ₹1,258.25 per share, attracting attention from investors.

Dr Reddys Laboratories Ltd experienced a substantial 0.31% boost in its share price and has garnered significant attention from the market. It's now trading at ₹1,256.90, making it an appealing option for investors.

The share price of Dr Reddys Laboratories Ltd has plummeted by -0.08%, signalling a challenging period. Currently trading at ₹1,253.00, this stock has caught the eye of bargain hunters, who may be considering their entry points.

In the financial arena, Dr Reddys Laboratories Ltd's stock price has increased by 0.25%, with its current market value per share resting at ₹1,254.00. This development highlights the stock's appeal to investors.

Dr Reddys Laboratories Ltd witnessed a -0.24% decrease in its share price, and it is currently trading at ₹1,250.45. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 18.4200, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd share price surged by 0.08%. With its current market price standing at ₹1,253.85 per share, this stock is garnering increased attention from the investment community.

Dr Reddys Laboratories Ltd witnessed a substantial 0.15% increase in its share price and is currently trading at ₹1,252.80. This remarkable performance has caught the eye of investors.

Dr Reddys Laboratories Ltd's share price has fallen by -0.39%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹1,251.55, and market participants are assessing the implications. The stock has a PE ratio of 18.4200, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

The share price of Dr Reddys Laboratories Ltd has plummeted by -0.00%, signalling a challenging period. Currently trading at ₹1,256.35, this stock has caught the eye of bargain hunters, who may be considering their entry points.

The share price of Dr Reddys Laboratories Ltd experienced an impressive 0.10% upswing and is currently trading at ₹1,256.40, indicating strong market sentiment.

Dr Reddys Laboratories Ltd share price has declined by -0.25%, and it's currently trading at ₹1,255.20. The stock maintains a PE of 18.4200, while the industry PE is 33.7937, prompting discussions about its valuation.

Dr Reddys Laboratories Ltd's shares saw an increase of 0.26%, reaching the current market price of ₹1,257.30. This development underscores the stock's growing popularity.

Dr Reddys Laboratories Ltd share price has declined by -0.21%, and it's currently trading at ₹1,253.95. The stock maintains a PE of 18.4200, while the industry PE is 33.7937, prompting discussions about its valuation.

Dr Reddys Laboratories Ltd shares saw a decrease of -0.48%, reaching a current market price of ₹1,256.00. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

Investors are buzzing as Dr Reddys Laboratories Ltd's share price soared by an impressive 0.96%. At this moment, it's actively trading at ₹1,264.05, presenting an enticing opportunity for those in the market.